中华口腔医学杂志
中華口腔醫學雜誌
중화구강의학잡지
Chinese Journal of Stomatology
2011年
9期
528-530
,共3页
孙传政%陈福进%宋明%蒋玉娥%杨安奎%陈艳峰
孫傳政%陳福進%宋明%蔣玉娥%楊安奎%陳豔峰
손전정%진복진%송명%장옥아%양안규%진염봉
黑色素瘤%口腔黏膜%预后
黑色素瘤%口腔黏膜%預後
흑색소류%구강점막%예후
Melanoma%Mouth mucosa%Prognosis
目的 探讨口腔黏膜黑色素瘤(oral mucosal melanoma,OMM)的治疗和预后。方法对51例OMM患者的临床资料进行回顾性分析。结果51例中病理证实淋巴结转移31例,其中29例限于Ⅰb~Ⅲ区;本组3、5年生存率分别为35%和21%。切取活检与切除活检、有无色素沉着未显著影响预后;接受手术+生物治疗或生物化疗者生存率显著高于其他治疗模式(P =0.003)。结论OMM颈淋巴结转移主要限于Ⅰb~Ⅲ区;切取活检和色素沉着未显著影响预后;该病预后差,手术+生物治疗或生物化疗有利于改善预后。
目的 探討口腔黏膜黑色素瘤(oral mucosal melanoma,OMM)的治療和預後。方法對51例OMM患者的臨床資料進行迴顧性分析。結果51例中病理證實淋巴結轉移31例,其中29例限于Ⅰb~Ⅲ區;本組3、5年生存率分彆為35%和21%。切取活檢與切除活檢、有無色素沉著未顯著影響預後;接受手術+生物治療或生物化療者生存率顯著高于其他治療模式(P =0.003)。結論OMM頸淋巴結轉移主要限于Ⅰb~Ⅲ區;切取活檢和色素沉著未顯著影響預後;該病預後差,手術+生物治療或生物化療有利于改善預後。
목적 탐토구강점막흑색소류(oral mucosal melanoma,OMM)적치료화예후。방법대51례OMM환자적림상자료진행회고성분석。결과51례중병리증실림파결전이31례,기중29례한우Ⅰb~Ⅲ구;본조3、5년생존솔분별위35%화21%。절취활검여절제활검、유무색소침착미현저영향예후;접수수술+생물치료혹생물화료자생존솔현저고우기타치료모식(P =0.003)。결론OMM경림파결전이주요한우Ⅰb~Ⅲ구;절취활검화색소침착미현저영향예후;해병예후차,수술+생물치료혹생물화료유리우개선예후。
Objective To investigate the treatment and prognosis of the patients with oral mucosal melanoma(OMM). Methods The clinicopathological and follow-up data of patients with OMM in Sun Yat-sen University Cancer Center from January 1976 to December 2005 were analyzed retrospectively.Results Fifty-one cases were analyzed. The pathological lymph node metastasis rate was 61% (31/51)and the affected sites were confined to level Ⅰb-Ⅲ (94%). The overall three year and five yearsurvival rates were 35% and 21% respectively. No significant difference of three year and five year survival rates were found between the group of incisional biopsy and the group of excisional biopsy. The prognosis was not affected by pigmentation. The survival rate of the patients receiving surgery combined with biotherapy or biochemotherapy was significantly higher than that of the patients treated by other modalities ( P = 0. 003 ).Conclusions In patients with OMM, lymph node metastasis was mostly confined to level Ⅰb-Ⅲ. Incisional biopsy and pigmentation were not associated with an unfavorable prognosis. The prognosis of the patients with OMM was poor and the patients may get a better prognosis by receiving surgery combined with biotherapy or biochemotherapy.